What evidence‑based screening tools (e.g., Structured Clinical Interview for DSM‑5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) disorders, Addiction Severity Index, Psychopathy Checklist‑Revised) and integrated treatment interventions should be used, and which outcome measures (psychiatric symptom burden, substance‑use frequency, recidivism) are recommended for a study of adults aged 18‑45 who are incarcerated, on probation, or referred by law‑enforcement agencies to examine the link between behavioral health factors and criminal behavior?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evidence-Based Screening, Interventions, and Outcomes for Justice-Involved Adults

For adults aged 18-45 in the criminal justice system, implement the Massachusetts Youth Screening Instrument-2 (MAYSI-2) adapted for adults alongside structured ACEs screening at intake, prioritize integrated trauma-informed treatment targeting dysregulation and substance use, and measure recidivism, psychiatric symptom burden, and substance-use frequency as primary outcomes.

Screening Tools

Mental Health and Substance Use Screening

  • The MAYSI-2 represents the gold standard for mental health and substance use screening in justice settings, validated as a 52-item self-report tool requiring no clinical expertise to administer, taking 10 minutes to complete, with strong psychometric properties across ages, ethnicities, and genders 1.

  • Universal ACEs screening should be implemented at all points of criminal justice contact (arrest, court diversion, detention, probation) to identify trauma exposure that drives both psychiatric symptoms and recidivism 1.

  • Structured diagnostic interviews using DSM-5 criteria should follow positive screens to establish formal diagnoses of mood disorders, anxiety disorders, PTSD, substance use disorders, and personality disorders—all strongly associated with criminal behavior 2.

  • The Psychopathy Checklist-Revised (PCL-R) demonstrates robust associations with violent crimes, crimes against property, and disorderly conduct, making it valuable for risk stratification 3.

Critical Screening Considerations

  • Screen for traumatic brain injury (TBI) in all justice-involved individuals, as TBI screening identifies unmet needs, informs individualized intervention plans, and predicts aggressive behaviors correlated with recidivism 1.

  • Bioassays (urine drug screens) provide objective substance use data but only detect most drugs used in the previous 2-3 days; hair analysis has contamination issues leading to false positives 1.

  • Implement screening at the earliest justice system contact point—88% of juvenile facilities screen for substance use and 99% screen for mental health, but adult systems lag behind 1.

Integrated Treatment Interventions

Trauma-Informed Behavioral Health Treatment

  • Target youth dysregulation, aggression, and empathy/callousness deficits within trauma-informed frameworks, recognizing that ACEs drive these criminogenic behaviors rather than viewing individuals as inherently aggressive or defiant 1.

  • Psychotropic medications should only be prescribed as part of comprehensive treatment plans that include individual therapy, group therapy, family therapy, and behavioral interventions (regular exercise, improved sleep hygiene, staff support) 1.

  • The Risk-Needs-Responsivity (RNR) model should conceptualize trauma's impact on aggressive and impulsive behaviors as the primary risk factor, not the behaviors themselves 1.

Substance Use Treatment

  • Drug use disorders carry the highest risk for lifetime crime (AOR=6.8) and incarceration (AOR=4.7), making addiction treatment the highest priority intervention 2.

  • Methadone demonstrates a protective role against violent crime commission and should be considered for opioid use disorders 3.

  • Community-based addiction treatment reduces justice involvement more effectively than detention-based approaches, particularly for individuals with serious offenses 1.

Addressing Comorbidity

  • Comorbid substance use and mental health disorders confer additional risk beyond single disorders, requiring integrated treatment addressing both simultaneously 4, 2.

  • Multimorbidity (increasing number of psychiatric disorders) escalates crime risk in a dose-dependent manner, necessitating comprehensive psychiatric assessment 2.

  • Personality disorders—particularly narcissistic (21%), antisocial (19%), and paranoid (14%)—increase crime risk and require specialized therapeutic approaches 3.

Recommended Outcome Measures

Primary Outcomes

  • Recidivism (re-arrest, reincarceration) serves as the most critical outcome measure for justice-involved populations, with ACEs, psychiatric symptoms, and substance use all independently predicting recidivism 1.

  • Psychiatric symptom burden should be measured using validated scales assessing depression, anxiety, PTSD, psychotic symptoms, and externalizing behaviors (aggression, impulsivity) 1, 5.

  • Substance-use frequency requires both self-report measures and objective bioassays to capture treatment response accurately 1.

Secondary Outcomes

  • Violent misconduct and weapon use during incarceration or supervision periods 1.

  • Academic engagement and school connectedness for younger adults, as these demonstrate protective effects against ACEs-related outcomes 1.

  • Successful probation completion rates, given lower completion among those with TBI and untreated psychiatric disorders 1.

Implementation Considerations

Equity and Cultural Factors

  • Racial and ethnic differences exist in how ACEs associate with recidivism: higher ACEs increase violent felony arrest odds for White males and Black females but not Black males or Hispanic males/females 1.

  • Tailor interventions to address differential cultural needs of Black, Latinx, and other minoritized individuals, given systemic racial bias in justice system contact and disproportionate minority representation 1.

  • Being White or female predicts co-occurring substance use and psychiatric medication use in community corrections 4.

System-Level Recommendations

  • Train all justice system personnel (law enforcement, judges, probation officers, treatment staff) in trauma-informed approaches through learning collaboratives and technology-supported workforce development 1.

  • Implement co-responder models pairing law enforcement with mental health professionals to maintain confidentiality while making informed referrals 1.

  • Establish memorandums of understanding between justice, behavioral health, and child welfare systems to coordinate care without perpetuating repetitive system involvement 1.

Common Pitfalls to Avoid

  • Do not use ACEs scores alone for clinical decision-making—they fail to account for frequency, intensity, chronicity, developmental timing, or protective factors 1.

  • Avoid viewing criminogenic behaviors (aggression, impulsivity, callousness) as fixed traits rather than trauma-driven symptoms amenable to treatment 1.

  • Do not punish individuals for refusing medical or mental health treatment; informed consent practices must govern all interventions 1.

  • Universal screening risks flooding child welfare systems with mandated reports and perpetuating systemic racial bias—implement safeguards through coordinated information-sharing protocols 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.